Cytokinetics has revealed the results from a phase 3 trial of its hypertrophic cardiomyopathy (HCM) drug aficamten that it hopes will allow it to compete with Bristol-Myers Squibb’s first-to-market ...

The United States stands as the global hub of technological innovation, hosting some of the most influential Information ...

NDA supported by positive Phase II registration study data in Chinese patients; follows Breakthrough Therapy Designation granted in 2023 — — Savolitinib has the potential to become the first selective ...

French ministers report Grok's sex-related content on the X platform to prosecutors French ministers have reported to prosecutors sexually explicit content generated by Elon Musk's xAI artificial ...